Capacity building in genomics medicine and molecular diagnostics: The case of Sri Lanka

Current Pharmacogenomics and Personalized Medicine

Volumn 10, Issue 3, 2012, Pages 185-194

  Manamperi, Aresha ^a   Huzair, Farah ^b  

^a UNIVERSITY OF KELANIYA   (Sri Lanka)

^b OPEN UNIVERSITY   (United Kingdom)

Author keywords

Genomics and development studies; Global personalized medicine; Health technology assessment in resourcelimited countries; LMICS; Low and middle income countries; Post war capacity building in pharmacogenomics; Sri Lanka

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; GENOMICS; HEALTH CARE COST; HUMAN; MOLECULAR DIAGNOSIS; MORTALITY; PERSONALIZED MEDICINE; PHARMACOGENOMICS; PRIVATE PRACTICE; SRI LANKA;

HARNESS;

EID: 84867013908     PISSN: 18756921     EISSN: 18756913     Source Type: Journal    
DOI: 10.2174/187569212802509960     Document Type: Article

References (20)

1. Global Forum for Health Research, 2012. Achievements and History. Available from: http://www.globalforumhealth.org/acchievements-and-history/. [Accessed June 3, 2012].
2. UNESCO, 2005. Universal Declaration on Bioethics and Human Rights, Article 2(f). Available from: http://portal.unesco.org/en/ev.php.URL_ID=31058&URL_DO=DO_TOPIC&URL_SECTION=201.html. [Accessed June 3, 2012].
3. Amorim C, Douste-Blazy P, Wirayuda H, et al. Oslo Ministerial Declaration-global health: a pressing foreign policy issue of our time. Lancet, 2007; 369(9570): 1373-8.
4. Annual Health Bulletin. Medical Statistics Unit, Department of Health, Ministry of Healthcare & Nutrition, Sri Lanka, 2007.
5. Ministry of Healthcare & Nutrition. Health Master Plan Sri Lanka - Healthy & Shining Island in the 21st Century. Vol.1. Ch.2 Colombo: Ministry of Healthcare & Nutrition, Sri Lanka, 2007.
6. Annual Health Bulletin. Medical Statistics Unit, Department of Health, Ministry of Healthcare & Nutrition, Sri Lanka, 2000.
7. Hapuarachchi HAC, Abeysundara S, Dayanath MYD, et al. Molecular markers of chloroquine resistance in Plasmodium falciparum in Sri Lanka: frequency before revision of antimalarial drug policy. Ann Trop Med Parasitol 2009; 103(4): 351-6.
8. Dissanayake VHW, Weerasekera LY, Gammulla CG, et al. Prevalence of genetic thrombophilic polymorphisms in the Sri Lankan population - implications for association study design and clinical genetic testing services. Exp Mol Pathol 2009; 87: 159-62.
9. Manamperi A, Nugawela P, Gunawardene NS, et al. RNA positive rates among anti-HCV reactive blood donors in Sri Lanka: A preliminary study. Ind J Med Microbiol 2010; 28(3): 264-5.
10. Manamperi A, Silva Gunawardene N, Wellawatta C, et al. Hepatitis B virus (HBV) genotypes in a group of Sri Lankan patients with chronic infection. Trop Biomed 2011; 28(2): 320-4.
11. Manamperi A, Hapuarachchi C, Silva Gunawardene N, et al. STR Polymorphisms in Sri Lanka: evaluation of forensic utility in identification of individuals and parentage testing, Ceylon Med J 2009; 55(3): 85-9.
12. HGSG, Human Genomics Strategy Group. 2012. Building on our Inheritance. Available from: http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_132382.pdf. [Accessed June 3, 2012]
13. USGS United States Geological survey. Available from: http://earthquake.usgs.gov/earthquakes/eqinthenews/2004/us2004slav/#details [Accessed June 3, 2012]
14. Ghobarah HA, Huth P, Russett B. The post-war public health effects of civil conflict. Soc Sci Med 2004; 59: 869-84.
15. Guribye E. No God and no Norway: collective resource loss among members of Tamil NGO's in Norway during and after the last phase of the civil war in Sri Lanka. Int J Ment Health Sys 2011; 5: 18.
16. Borda-Rodriguez A, Huzair F. Revisiting the Paris Declaration: Pharmacogenomics and personalized medicine as accelerators for development aid and effectiveness Curr Pharmacogenomics Person Med 2011; 9(4): 240-2.
17. O'Meara MM, Disis ML. Therapeutic cancer vaccines and translating vaccinomics science to the global health clinic: emerging applications toward proof of concept. OMICS 2011; 15(9): 579-88.
18. Huzair F, Borda-Rodriguez A, Upton M. Twenty-first century vaccinomics innovation systems: capacity building in the global South and the role of Product Development Partnerships (PDPs). OMICS 2011; 15(9): 539-43.
19. Loukas A, Gaze S, Mulvenna JP, et al. Vaccinomics for the major blood feeding helminths of humans. OMICS 2011; 15(9): 567-77.
20. Poland GA, Kennedy RB, Ovsyannikova IG. Vaccinomics and personalized vaccinology: is science leading us toward a new path of directed vaccine development and discovery? PLoS Pathog 2011; 7(12): e1002344.